Holen Sie sich die Stockscreener-App
2.56
1.16%
-0.03
Handel nachbörslich:
2.50
-0.06
-2.34%
Schlusskurs vom Vortag:
$2.59
Offen:
$2.57
24-Stunden-Volumen:
12,596
Relative Volume:
0.03
Marktkapitalisierung:
$2.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.29%
1M Leistung:
-11.42%
6M Leistung:
-84.77%
1J Leistung:
-94.36%
1-Tages-Spanne:
$2.48
$2.57
1-Wochen-Bereich:
$2.3001
$2.68
52-Wochen-Spanne:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Firmenname
Psyence Biomedical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare PBM vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
2.56 | 2.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru
Psyence Biomed announces export of GMP-manufactured natural psilocybin (NPX-5) to Australia for ongoing clinical trial phase IIb - marketscreener.com
Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial - The Manila Times
Natural psilocybin shipped to Australia for cancer palliative care trial - Stock Titan
Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes - TipRanks
Large share exchange boosts Psyence Labs’ stake in Psyence Biomedical (PBM) - Stock Titan
VIX Spike: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn
Aug EndMonth: Can Psyence Biomedical Ltd Equity Warrant beat the S P 5002025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyGap Down & Accurate Technical Buy Alerts - mfd.ru
PBM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PBM Earnings History & Surprises | EPS & Revenue Results | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
PBM PE Ratio & Valuation, Is PBM Overvalued - Intellectia AI
Movement Recap: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Psyence Biomedical shares rise following equity investment agreement - MSN
Psyence BioMed Announces Exercise Of Put Option By Psyence Labs; Stock Up - Nasdaq
Psyence Biomedical stock gains on equity investment deal By Investing.com - Investing.com Canada
Aug Rallies: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Trade Ideas & AI Forecast Swing Trade Picks - baoquankhu1.vn
Is Psyence Biomedical Ltd.’s ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - mfd.ru
Psyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction Breakthrough - MSN
Psyence BioMed Exercises Put Option to Invest in PsyLabs - Intellectia AI
Psyence Biomedical Cedes 49.98% Stake to PsyLabs in US$5 Million Share Swap - TipRanks
Psyence Biomedical Ltd. Invests in Psyence Labs Ltd. to Enhance Strategic Relationship and Supply Chain Capabilities - Quiver Quantitative
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment - The Spec
Psyence Biomedical Shareholders Approve Board, Auditor and Share Consolidation Authority - The Globe and Mail
PBM SEC FilingsPsyence Biomedical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
Does Psyence Biomedical Ltd. stock have upside surprise potential2025 Buyback Activity & Reliable Entry Point Trade Alerts - mfd.ru
Weiner discloses 51,850-share, 5.07% stake in Psyence Biomedical (PBM) - Stock Titan
Growth Review: Does Bitfarms Ltd align with a passive investing strategyTrade Performance Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn
Will Psyence Biomedical Ltd. outperform its industry peersMarket Sentiment Report & Precise Trade Entry Recommendations - mfd.ru
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders - Bitget
Psyence Biomedical Ltd. Announces Shareholder Meeting Results, Directors Elected and Share Consolidation Authority Granted - Quiver Quantitative
Psilocybin developer’s investors back plan to combine shares up to 250-for-1 - Stock Titan
Sectors Review: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Weekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025Oil Prices & AI Forecast for Swing Trade Picks - mfd.ru
Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - The Globe and Mail
PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks
Psyence BioMed Enters Put Option Agreement with PsyLabs - Intellectia AI
Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - The Spec
Psyence BioMed Approves Put Option Agreement With PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - 富途牛牛
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks
Activity Recap: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsIPO Watch & AI Forecasted Entry/Exit Points - baoquankhu1.vn
PSYENCE BIOMEDICAL LTD TO PAY KAOS CAPITAL $1.5 MILLION IN SETTLEMENT - Intellectia AI
Psyence Biomedical announces settlement of shareholder litigation - TipRanks
Psyence Biomed announces settlement of shareholder litigation - marketscreener.com
Psyence Biomedical Ltd. Reaches Settlement Agreement with KAOS Capital Ltd. to Resolve Shareholder Claims - Quiver Quantitative
Psyence BioMed Announces Settlement of Shareholder Litigation - ChartMill
Published on: 2026-02-11 15:38:29 - mfd.ru
Is Psyence Biomedical Ltd. stock forming a triangle patternWeekly Trend Recap & Risk Managed Investment Signals - mfd.ru
Revenue Check: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500July 2025 Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Final Week: Is Xenon Pharmaceuticals Inc a play on infrastructure spendingBond Market & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)
Es liegen keine Finanzdaten für Psyence Biomedical Ltd (PBM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):